Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Robertson

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphomaM J Keating, P McLaughlin, W Plunkett, et al.
Blood|August 1, 1994
2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disordersS O'Brien, R Kurzrock, M Duvic, et al.
Blood|August 8, 1998
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapyM J Keating, S O'Brien, S Lerner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factorE Estey, P Thall, M Andreeff, et al.
Cancer|June 15, 1994
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemiaJ E Cortes, H Kantarjian, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Richter's syndrome: a report on 39 patientsL E Robertson, W Pugh, S O'Brien, et al.
Blood|July 1, 1992
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysisL E Robertson, Y O Huh, J J Butler, et al.
Seminars in Hematology|January 1, 1994
Fludarabine phosphate: a new active agent in hematologic malignanciesM J Keating, S O'Brien, W Plunkett, et al.
Blood|November 1, 1995
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseS O'Brien, H Kantarjian, M Keating, et al.
Leukemia & Lymphoma|January 1, 1994
The expanding role of fludarabine in hematologic malignanciesM J Keating, S O'Brien, L E Robertson, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphomaM J Keating, P McLaughlin, W Plunkett, et al.
Blood|August 1, 1994
2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disordersS O'Brien, R Kurzrock, M Duvic, et al.
Blood|August 8, 1998
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapyM J Keating, S O'Brien, S Lerner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factorE Estey, P Thall, M Andreeff, et al.
Cancer|June 15, 1994
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemiaJ E Cortes, H Kantarjian, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Richter's syndrome: a report on 39 patientsL E Robertson, W Pugh, S O'Brien, et al.
Blood|July 1, 1992
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysisL E Robertson, Y O Huh, J J Butler, et al.
Seminars in Hematology|January 1, 1994
Fludarabine phosphate: a new active agent in hematologic malignanciesM J Keating, S O'Brien, W Plunkett, et al.
Blood|November 1, 1995
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseS O'Brien, H Kantarjian, M Keating, et al.
Leukemia & Lymphoma|January 1, 1994
The expanding role of fludarabine in hematologic malignanciesM J Keating, S O'Brien, L E Robertson, et al.
Pageof 5